STOCK TITAN

ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
ANI Pharmaceuticals, Inc. (ANIP) will be represented by President & CEO Nikhil Lalwani at the Piper Sandler 35th Annual Healthcare Conference in New York City on November 28, 2023. The webcast of the event will be available on the company's website, and 1x1 meetings can be scheduled by contacting corporateaccess@psc.com.
Positive
  • None.
Negative
  • None.

BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper Sandler 35th Annual Healthcare Conference in New York City as follows:

Date:    Tuesday, November 28, 2023
  
Time:1:00pm – 1:25pm ET
  
Webcast:  Click Here
  

To schedule a 1x1 meeting with the Company, please contact corporateaccess@psc.com.

The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 30 days.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

 


ANI Pharmaceuticals, Inc. will participate at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.

President & CEO Nikhil Lalwani will represent ANI Pharmaceuticals, Inc. at the conference.

1x1 meetings with ANI Pharmaceuticals, Inc. can be scheduled by contacting corporateaccess@psc.com.

The webcast of the event will be accessible on ANI Pharmaceuticals, Inc.'s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations.

The replay of the webcast will be accessible for 30 days.
ANI Pharmaceuticals Inc

NASDAQ:ANIP

ANIP Rankings

ANIP Latest News

ANIP Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Other, Manufacturing, Biological Product (except Diagnostic) Manufacturing
US
Baudette

About ANIP

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.